当前位置：首页 > 文献互助 > 互助详情

期刊论文A platform for personalized ASO therapeutics复制

用户Uxwwz7TAhssw 2个月前 72 已完结

1. 系统已在2025-04-12 11:52:25对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1038/d41573-025-00034-w复制

文献链接: https://www.nature.com/articles/d41573-025-00034-w复制

其他信息:

出版社: Springer Science and Business Media LLC
作者: Sarah Crunkhorn
全文下载地址: https://www.nature.com/articles/d41573-025-00034-w.pdf

上一篇：Use of long-acting injectable cabotegravir/rilpivirine in people with HIV and adherence challenges

下一篇：Oral STING agonist inhibits tumour growth

互助时间线

2025-04-07 09:04:21 [完结求助]

楼主确认了皮一下很开心应助的文件是正确的, 求助状态变成已完结

2025-04-05 11:52:25 [上传文件]

皮一下很开心上传了文件(pdf 534.33 KB), 求助状态变成待确认

2025-04-03 20:24:27 [发起求助]

最新发布的求助

A retrospective Cohort study on the effect of the LOw-molecular weighT heparin (LMWH) nadroparin dose on anti-XA levels in a mixed medical-surgical ICU population: CLOT-Xa 31分钟前

Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial 35分钟前

男性患者的 delbrueckii 乳杆菌尿路感染 42分钟前

Design and Biological Evaluation of Long-Term Sustained Release Taxanes Loaded Human Serum Albumin Nanoparticles 54分钟前

Controversies in the Management of Preschool Asthma 1小时前

Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies 1小时前

Accelerating Effect of the Addition of HFIP on the Oxidation of Alcohols Using TEMPO/PIDA 1小时前

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT 1小时前

Molecular Dynamics Simulation of Antimicrobial Peptide CM15 in Staphylococcus Aureus and Escherichia coli Model Bilayer Lipid 1小时前

Intraoperative seizures during neuro-oncological supratentorial surgery: the role of prophylaxis with levetiracetam and intraoperative monitoring in a consecutive series of 353 patients 2小时前

Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical Trial 2小时前

Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial 2小时前